Pericardiotomy as a novel treatment for heart failure with preserved ejection fraction.

Heart Fail Rev

Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN, USA.

Published: January 2025

AI Article Synopsis

  • * In HFpEF patients, factors like obesity and heart conditions can cause increased pressure in the heart due to the restrictive nature of the pericardium.
  • * Research is exploring the potential of pericardiotomy (surgical removal of the pericardium) as a new treatment option for HFpEF.

Article Abstract

The pericardium plays an important role in modulating cardiac performance and hemodynamics in patients with heart failure with preserved ejection fraction (HFpEF). Pericardial constraint increases filling pressures in patients with HFpEF, particularly those with the obesity phenotype, atrial myopathy, right ventricular dysfunction, and tricuspid regurgitation. Preclinical and early stage clinical studies indicate that pericardiotomy may become a novel treatment for HFpEF. This review summarizes and discusses the pathophysiology of pericardial restraint and the possibility of pericardiotomy in HFpEF.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10741-024-10451-5DOI Listing

Publication Analysis

Top Keywords

pericardiotomy novel
8
novel treatment
8
heart failure
8
failure preserved
8
preserved ejection
8
ejection fraction
8
treatment heart
4
fraction pericardium
4
pericardium plays
4
plays role
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!